Sarmad Sabah Nasser Al-Edresi

Diclofenac Sodium is a non-steroidal anti-inflammatory drug (NSAID), which has analgesic, anti-inflammatory, and antipyretic effects. Diclofenac sodium topically (gel 1%) has mild site reactions, with a relatively short duration of action and low permeability need for multiple uses. This study aimed to produce hydrogel of proniosomes to enhancing solubility and permeation of diclofenac topical used. Proniosome was prepared by using the coacervation phase separation method using Span 60 and Tween 80, lecithin and cholesterol. The hydrogel base was prepared from carbopol 940, then Proniosome was mixed in ratio one to one (1:1). Viscosity, release, permeation and stability were assayed. Results revealed a successfully prepared hydrogel loaded with proniosomes, which was consequently loaded with its payload. The release study carried out in vitro revealed a control-released behaviour over 28 hours which was 6 fold higher than the ordinary preparation i.e. lack of proniosomes. To sum up, the hydrogel of Proniosome preparation loading with Diclofenac Sodium was approved to overcome controlled release and skin permeation problems.

Objective: The present study was performed to compare the quality of conventional tablets loaded with candesartan cilexetil. The selected candesartan cilexetil tablets were commercialized in the Iraq market and produced by different companies. Methods: Different batches of candesartan cilexetil oral tablets (the concentration of candesartan was 8 mg) were subjected to quality control tests. Tests included weight variation, friability, hardness, drug content, disintegration time and in vitro release study. The protocols of these tests were performed according to USP pharmacopeia. Results: The results, in this study, revealed that all the used batches of candesartan cilexetil oral tablets complied with the specification of USP pharmacopeia for weight uniformity, friability value (% loss) was<1. Hardness results of the tablets were 4.9-6.6 Kg/cm2, which was within the required limits (i.e. 4-8 Kg/cm2). Disintegration time was<15 min in both Simulated Gastric Fluid (SGF) and Simulated Intestinal Fluid (SIF). The percentage of drug content in all marketed tablets was found between 96.2 % and 99.8 %, reflecting compliance with the pharmacopeia limits (i.e. 85-115 %). An in vitro release study indicated that the release of all marketed tablets exceeds 80 % within 15 min. Conclusion: All the studied tablets, loaded with candesartan cilexetil, were produced within the standard criteria of tablet production. The quality control analysis of the selected tablets, in this study, revealed satisfactory pharmaceutical properties (including safety and effectiveness) that comply within the limits of USP pharmacopeia.

This research aimed to enhance the loading capacity of kojic acid dipalmitate (KDP) to liposomes. Liposomes were prepared by the thin-lipid film hydration method. The particle size, polydispersity index and zeta-potential were analysed using photon correlation spectroscopy. KDP was loaded into liposomes by active loading method. The stability study was studied for over 2 months. Atomic force microscopy was used to study the morphology of the liposomes. The particle sizes of liposomes were in the range of 80-100 nm. Liposomes particle were homogeneous with PDI ≤ 0.2 and zeta-potential of -0.5 to - 0.6 mV. No significant particle size changes over time were seen, reflecting stable liposomes. The KDPloading capacity increased from 0.61% to 28.12 % with homogeneously distributed particles. Liposomes were stable and loaded with KDP with enhanced loading capacity, allowing a promising formulation of KDP to enhance its bioavailability and therapeutic capacity.

Aggregation of amyloid β1–42 (Aβ1–42) peptide within the brain is considered one of the main causes of the neuropathological changes associated with Alzheimer's disease. Resveratrol is a well-known antioxidant but has also been reported to bind to Aβ1–42 peptide, thereby reducing aggregation. However, little is known of the precise mechanism by which resveratrol reduces Aβ1–42 peptide aggregation. Using the thioflavin-T assay, the ability of resveratrol to reduce the extent of Aβ1–42 peptide aggregation was investigated. The findings of the present study demonstrate that interaction of resveratrol with Aβ1–42 peptide resulted in the cleavage of Aβ1–42 peptide into smaller fragments, as detected by matrix assisted laser desorption ionization-time of flight mass spectrometry. Atomic force microscopy analyses revealed Aβ1–42 peptide, under control conditions, aggregated into oligomers, protofibrils, and fibrils, whereas there was a distinct lack of these structures when Aβ1–42 peptide was incubated with resveratrol. Following 10 days incubation of Aβ1–42 peptide with resveratrol, particles with a mean z-height of 1.940 nm (range 0.675–3.275 nm) were observed, which are characteristic of shorter peptide species. In cell-based studies, resveratrol significantly reduced the cytotoxicity of Aβ1–42 peptide toward SH-SY5Y human neuroblastoma cells, suggesting a protective effect of the polyphenol. We therefore propose a novel mechanism by which resveratrol disrupts Aβ1–42 aggregation by mediating fragmentation of Aβ1–42 into smaller peptides, which have no propensity to aggregate further.

Purpose: Kojic dipalmitate (KDP), dissolved in oil medium, have been tested for their capability to permeate through artificial skin using Franz cells. Methods: It has been discovered that there was no significant variation in terms of drug release between nano- creams and normal creams at P-value> 0.05. KDP, incorporated into normal and nano- creams, was applied into the skin of a male Wistar rat. The storage behavior of KDP, loaded in nano-creams (diameter< 350 nm) and applied to the hair follicles was investigated.

Virgin coconut oil (VCO)-in-water, nano-emulsion in the form of cream stabilized by Emulium Kappa® as an emulsifier, was prepared by using the Emulsion Inversion Point method. A nano-emulsion with droplet size <300 nm was then obtained. VCO has recently become a more popular new material in the cosmetic industries. Emulium Kappa® is an ionic emulsifier that contains sodium stearoyl lactylate, the active whitening ingredient was Kojic Dipalmitate. Ostwald ripening is the main destabilizing factor for the nano-emulsion. This decline can be reduced by adding non-soluble oil, namely squalene, to the virgin coconut oil. We tested VCO:squalene in the ratios of 10:0, 9.8:0.2, 9.6:0.4, 9.4:0.6, 9.2:0.8, 9:1 and 8:2 and discovered that squalene's higher molecular weight (above critical molecular weight) resulted in low polarity and insolubility in the continuous phase. The continuous partitioning between the droplets results in the decline of Ostwald ripening. Furthermore, flocculation may occur due to the instability of nano-emulsion, especially for the preparations with little or no squalene at all. The stability of the nano-emulsion was evaluated by the electrophoretic properties of the emulsion droplets. The zeta potential values for the emulsion increased as the percentage of squalene oil increased.

Nanotech France 2020, the 6th edition of the international conference and exhibition, brings together leading scientists, researchers, engineers, practitioners, technology developers and policy makers in nanotechnology to exchange information on their latest research progress and innovation. Participants from the top international academic, government and private industry labs of different disciplines participate in Nanotech France 2020 to identify new technology trends, development tools, product opportunities, R&D collaborations, and commercialization partners. It is an excellent event for students to meet and discuss with lead researchers. The conference provides an unprecedented opportunity to discover innovation in the area of nanotechnology and new business opportunities. It is among the most important events in terms of international regulatory policies and it is open to the participation of private companies. The conference covers all frontier topics in nanotechnology. The conference includes plenary lectures, Keynote lectures and invited talks by eminent personalities from around the world in addition to contributed papers both oral and poster presentations.

Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business. Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer Conference Series LLC Ltd Conferences gaining more Readers and Visitors Conference Series LLC Ltd Web Metrics at a Glance 3000+ Global Events 100 Million+ Visitors 75000+ Unique visitors per conference 100000+ Page views for every individual conference Unique Opportunity! Online visibility to the Speakers and Experts

Conferenceseries LLC Ltd is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “34th International Conference on Nanomedicine & Pharmaceutical Nanotechnology (Nanomed 2020) scheduled to be held during October 14-15, 2020 at Zurich, Switzerland. The conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Nanotechnology and Nanomedicine. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Nanotechnology and Nanomedicine. The main theme of the conference is “Advancing Prominence of Nanomedicine & Nanotechnology to Drive the Pharma Industry”. Why to attend? Nanomed 2020 offers a fantastic opportunity to meet and make new contacts in the field of Nanotechnology & Materials Science and Engineering, by providing collaboration spaces and break-out rooms with tea and lunch for delegates between sessions with invaluable networking time for you. It allows delegates to have issues addressed on Nanotechnology by recognized global experts who are up to date with the latest developments in the Nanotechnology field and provide information on new techniques and technologies. This International Nanotechnology conference will feature world renowned keynote speakers, plenary speeches, young research forum, poster presentations, technical workshops and career guidance sessions. Nanomedicine is a uniquely addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics. Nanomed 2020 is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community. Target Audience: Nanotechnology Professionals Directors of companies in the field of Nanotechnology Leading scientists Biomedical Engineering Medicine and Pharmaceuticals Professors Fellows or postdoctoral students Researchers, CEOs Business Delegates Doctors Young research scientists Medical Colleges Nanotechnology Associations and Societies Manufacturing Medical Devices Companies Healthcare professionals Founders and Employees of the related companies Clinical investigators Sessions/Tracks Track 1: Nanomedicine and Nanotechnology Nanomedicine is a division of medicine that smears the knowledge and tools of nanotechnology to the inhibition and treatment of disease. Nanomedicine includes the use of nanoscale resources, such as biocompatible nanoparticles and nanorobots for sending, diagnosis, sensing or actuation drives in a living creature. Nanotechnology has many descriptions but in general it is the use and presentation of materials with sizes in the nanometre range. Just as a millimetre is one-thousand of a metre, a nanometre is one-millionth of a millimetre. In more comprehensible terms, a human hair is roughly 90,000 nanometres in diameter and the developing science and industry of nanotechnology utilises materials below 2000 nanometres. Assistances of working at this very small scale have been seen for many years over such assorted areas as electronics and energy storage to sunscreens and food packaging. Nanotechnology | Nanomaterials | Nanodrugs | Pharmaceutical Conferences | Pharmaceutical Events | Drug Delivery Events | Healthcare Conferences | Nanomedicine Meetings Related Conferences: 3rd International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine February 24-25, 2020 Rome, Italy; 2nd International Conference on Nanomedicine and Nanotechnology April 17-18, 2020 Kuala Lumpur, Malaysia; 17th Nanotechnology and Nanomedicine Congress April 20-21, 2020 Tokyo, Japan; 16th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology May 04-05, 2020 Amsterdam, Netherlands; 28th International Conference on Nanomedicine and Nanomaterials May 29-30, 2020 Istanbul, Turkey; 5th Annual Congress on Nanomedicine and Drug Delivery August 10-11, 2020 Bangkok, Thailand; 2nd European Congress on Nanomedicine and Drug Delivery Systems December 07- 08, 2020 Paris, France; 31st European Congress on Nanotechnology and Materials Engineering February 12-13, 2020 Paris, France; 3rd International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine February 24-25, 2020 Rome, Italy; 18th International Conference on Emerging Materials and Nanotechnology February 26-27, 2020 London, UK Societies in Europe: Nanotechnology Industries Association, Royal Microscopically Society, Royal Society - Nanotechnology and Nanoscience, British Society for Nanomedicine, European Society for Nanomedicine, French Society for Nanomedicine, European Nano Business Association, European Society for Precision Engineering and Nanotechnology, Czech Nanotechnology Industries Association and Erwin Schrodinger Society for Nanoscience’s Societies in USA: American Academy of Nanomedicine, Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nano Medicine, International Association of Nanotechnology and Graphene Stakeholders Association Societies in Asia: National Centre for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine Track 2: Nano Pharmaceuticals Nanopharmaceuticals offer the capability to detect infections at much earlier stages and the diagnostic submissions could build upon conventional actions using nanoparticles. Nanopharmaceuticals signify an emerging field where the dimensions of the drug particle or a therapeutic delivery system work at the nanoscale. In the pharmaceutical industry, a long upright issue is the effort of delivering the suitable dose of a particular active agent to specific disease site. Nanopharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which advises site-specific targeting of active agents. Such accurate targeting via Nanopharmaceuticals reduces toxic systemic side effects, subsequent in better patient compliance. In today’s world economy, a pharmaceutical industry faces huge pressure to deliver high-quality yields to patients while maintaining profitability. Therefore pharmaceutical companies are applying nanotechnology to improve or supplement drug target detection and drug delivery. Nanopharmaceuticals condense the cost of drug discovery, design & development and improve the drug delivery process. This results in the enhanced Research & Development success rate which enables earlier introduction of new, cost-effective products to the marketplace. Nanotechnology | Nanomaterials | Nanodrugs | Pharmaceutical Conferences | Pharmaceutical Events | Drug Delivery Events | Healthcare Conferences | Nanomedicine Meetings Related Conferences: European Meeting on Materials Science and Nanotechnology March 09-10, 2020 Rome, Italy; 4th International Conference and Exhibition on Material Science and Nanotechnology March 23-24, 2020 Dubai, UAE; 34th International Conference on Advanced Nanoscience and Nanotechnology April 27-28, 2020 Amsterdam, Netherlands; 36th World Congress on Materials Science and Nanotechnology May 13-14, 2020 Tokyo Japan; 25th World Congress On Nanomaterials and Nanotechnology May 25-26, 2020 Osaka, Japan; 23rd World Nanotechnology Congress May 29-30, 2020 Istanbul, Turkey; 33rd International Conference on Nanomaterials and Nanotechnology June 15-16, 2020 London, UK; 26th International Conference on Advanced Materials, Nanotechnology and Engineering June 22-23, 2020 Brisbane, Australia Societies in Europe: European Nanoscience and Nanotechnology Association, Nanotechnology Industries Association, Russian Society of Scanning Probe Microscopy and Nanotechnology Societies in USA: American Nano Society, International Association of Nanotechnology, Nanotechnology and Nanoscience Student Association (NANSA) , American Bar Association Section Nanotechnology Project, American Chemical Society, Microscopy society of America Societies in Asia: Asian Nanoscience and Nanotechnology Association, International association of Nanotechnology, Chinese Society of Nanotechnology , Korean Society of Nanotechnology, Japanese Society of Nanotechnology Track 3: Nanomedicine and Biomedical Applications Nanomedicine is basically the use of nanotechnologies in a healthcare related and the popular of aids that have already been seen include the use of nanoparticles to advance the behaviour of drug substances. In today, nanomedicines are used worldwide to increase the actions on patients suffering from a range of disorders including ovarian and breast cancer, fungal infections, kidney disease elevated cholesterol, menopausal symptoms, chronic pain, multiple sclerosis, asthma and emphysema. Nanomedicines that are presently available are overcoming some of the problems practiced by normal medical appeal in bringing the benefit from the drug molecules used. In some cases the drugs have very little solubility in water and the human body struggles to engage enough to treat the condition. In other cases, the drug molecule is fascinated well but the body removes the drug before it has had long sufficient to provide benefits. Drugs may lead to side-effects due to reduced delivery at the real site of disease. For example, drugs that are targeting cancers must avoid healthy tissues and organs or damage can be produced. Nanomedicines therefore can play a significant role in confirming enough of the drug enters the body, the entered drug stays in the body for long stages and is targeted exactly to the parts that need treatment. Nanotechnology | Nanomaterials | Nanodrugs | Pharmaceutical Conferences | Pharmaceutical Events | Drug Delivery Events | Healthcare Conferences | Nanomedicine Meetings Related Conferences: World Congress on Nanotechnology and Advanced Materials July 09-10, 2020 Geneva, Switzerland; 36th International Conference on Advanced Nanotechnology September 14-15, 2020 Dubai, UAE; 21st International Conference and Exhibition on Materials Science, Nanotechnology and Engineering September 21-22, 2020 Milan, Italy; 6th International Conference and Exhibition on Nanotechnology, Artificial Intelligence and IOT October 12-13, 2020 Sydney, Australia; 21st World Summit on Nanotechnology and Expo December 10-11, 2020 Osaka, Japan; International Conference on Material Science and Nanotechnology November 02-03, 2020 Sydney, Australia; 25th International Conference on Advanced Materials & Nanotechnology November 23-24, 2020 Barcelona, Spain; 33rd World Congress and Expo on Nano materials and Nanotechnology November 23-24, 2020 Edinburgh, Scotland Societies in Europe: Nanotechnology Industries Association, Royal Microscopically Society, Royal Society - Nanotechnology and Nanoscience, British Society for Nanomedicine, European Society for Nanomedicine, French Society for Nanomedicine, European Nano Business Association, European Society for Precision Engineering and Nanotechnology, Czech Nanotechnology Industries Association and Erwin Schrödinger Society for Nanoscience’s Societies in USA: American Academy of Nanomedicine, Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nano Medicine, International Association of Nanotechnology and Graphene Stakeholders Association Societies in Asia: National Centre for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine Track 4: Pharmaceutical Nanotechnology Pharmaceutical Nanotechnology deals with developing new technologies for emerging customized solutions for drug delivery systems. The drug delivery system absolutely impacts the rate of distribution, absorption, metabolism, and excretion of the drug or other associated chemical substances in the body. In accumulation to this the drug delivery system also permits the drug to bind to its target receptor and affect that receptor’s signalling and activity. Pharmaceutical nanotechnology holds applications of nanoscience to pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor. Nanotechnology | Nanomaterials | Nanodrugs | Pharmaceutical Conferences | Pharmaceutical Events | Drug Delivery Events | Healthcare Conferences | Nanomedicine Meetings Related Conferences: 3rd International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine February 24-25, 2020 Rome, Italy; 2nd International Conference on Nanomedicine and Nanotechnology April 17-18, 2020 Kuala Lumpur, Malaysia; 17th Nanotechnology and Nanomedicine Congress April 20-21, 2020 Tokyo, Japan; 16th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology May 04-05, 2020 Amsterdam, Netherlands; 28th International Conference on Nanomedicine and Nanomaterials May 29-30, 2020 Istanbul, Turkey; 5th Annual Congress on Nanomedicine and Drug Delivery August 10-11, 2020 Bangkok, Thailand; 2nd European Congress on Nanomedicine and Drug Delivery Systems December 07- 08, 2020 Paris, France; 31st European Congress on Nanotechnology and Materials Engineering February 12-13, 2020 Paris, France; 3rd International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine February 24-25, 2020 Rome, Italy; 18th International Conference on Emerging Materials and Nanotechnology February 26-27, 2020 London, UK Societies in Europe: European Nanoscience and Nanotechnology Association, Nanotechnology Industries Association, Russian Society of Scanning Probe Microscopy and Nanotechnology Societies in USA: American Nano Society, International Association of Nanotechnology, Nanotechnology and Nanoscience Student Association (NANSA) , American Bar Association Section Nanotechnology Project, American Chemical Society, Microscopy society of America Societies in Asia: Asian Nanoscience and Nanotechnology Association, International association of Nanotechnology, Chinese Society of Nanotechnology , Korean Society of Nanotechnology, Japanese Society of Nanotechnology Track 5: Smart Drug Delivery Technology With the unparalleled evolutions of biomedical nanotechnology during the past few periods, conservative drug delivery systems have been complicated into smart DDSs with stimuli-responsive features. Advancing from the response to exact internal or external triggers, those well-defined Nano platforms can grow the drug targeting efficacy, in the meantime; decrease side effects/toxicities of payloads, which are key aspects for improving patient compliance. In these field, different smart DDSs has been profusely established for numerous intriguing schemes, such as stimuli-responsive liposomes, polymeric nanoparticles, metals/metal oxides, and exosomes. Nanotechnology | Nanomaterials | Nanodrugs | Pharmaceutical Conferences | Pharmaceutical Events | Drug Delivery Events | Healthcare Conferences | Nanomedicine Meetings Related Conferences: European Meeting on Materials Science and Nanotechnology March 09-10, 2020 Rome, Italy; 4th International Conference and Exhibition on Material Science and Nanotechnology March 23-24, 2020 Dubai, UAE; 34th International Conference on Advanced Nanoscience and Nanotechnology April 27-28, 2020 Amsterdam, Netherlands; 36th World Congress on Materials Science and Nanotechnology May 13-14, 2020 Tokyo Japan; 25th World Congress On Nanomaterials and Nanotechnology May 25-26, 2020 Osaka, Japan; 23rd World Nanotechnology Congress May 29-30, 2020 Istanbul, Turkey; 33rd International Conference on Nanomaterials and Nanotechnology June 15-16, 2020 London, UK; 26th International Conference on Advanced Materials, Nanotechnology and Engineering June 22-23, 2020 Brisbane, Australia Societies in Europe: Nanotechnology Industries Association, Royal Microscopically Society, Royal Society - Nanotechnology and Nanoscience, British Society for Nanomedicine, European Society for Nanomedicine, French Society for Nanomedicine, European Nano Business Association, European Society for Precision Engineering and Nanotechnology, Czech Nanotechnology Industries Association and Erwin Schrodinger Society for Nanoscience’s Societies in USA: American Academy of Nanomedicine, Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nano Medicine, International Association of Nanotechnology and Graphene Stakeholders Association Societies in Asia: National Centre for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine Track 6: Nanobiotechnology Nanobiology, bionanotechnology are standings that refer to the connection of nanotechnology and biology. This discipline helps to designate the merger of biological study with various fields of nanotechnology. This technical method of biology allows scientists to visualize and create systems that can be used for biological research. Biologically stimulated nanotechnology uses biological systems as the encouragements for technologies not yet created. Nanotechnology | Nanomaterials | Nanodrugs | Pharmaceutical Conferences | Pharmaceutical Events | Drug Delivery Events | Healthcare Conferences | Nanomedicine Meetings Related Conferences: World Congress on Nanotechnology and Advanced Materials July 09-10, 2020 Geneva, Switzerland; 36th International Conference on Advanced Nanotechnology September 14-15, 2020 Dubai, UAE; 21st International Conference and Exhibition on Materials Science, Nanotechnology and Engineering September 21-22, 2020 Milan, Italy; 6th International Conference and Exhibition on Nanotechnology, Artificial Intelligence and IOT October 12-13, 2020 Sydney, Australia; 21st World Summit on Nanotechnology and Expo December 10-11, 2020 Osaka, Japan; International Conference on Material Science and Nanotechnology November 02-03, 2020 Sydney, Australia; 25th International Conference on Advanced Materials & Nanotechnology November 23-24, 2020 Barcelona, Spain; 33rd World Congress and Expo on Nano materials and Nanotechnology November 23-24, 2020 Edinburgh, Scotland Societies in Europe: European Nanoscience and Nanotechnology Association, Nanotechnology Industries Association, Russian Society of Scanning Probe Microscopy and Nanotechnology Societies in USA: American Nano Society, International Association of Nanotechnology, Nanotechnology and Nanoscience Student Association (NANSA) , American Bar Association Section Nanotechnology Project, American Chemical Society, Microscopy society of America Societies in Asia: Asian Nanoscience and Nanotechnology Association, International association of Nanotechnology, Chinese Society of Nanotechnology , Korean Society of Nanotechnology, Japanese Society of Nanotechnology

Conference Series LLC LTD, the world’s leading Scientific Event Organizer invites all the Speakers, Delegates, Researchers, Students and Industrialists to attend 31st World Nano Conference (Nano 2020) during November 22-23, 2020 at Barcelona, Spain around the theme Scrutinizing the latest approaches in the sphere of Nanotechnology. Following the success of previous Nano Conference held during May 20-21, 2019 at Zurich, Switzerland we are now delighted to welcome you to 31st World Nano Conference (Nano 2020) during November 22-23, 2020 at Barcelona, Spain aimed to provide an opportunity for all the Attendees to meet, interact and exchange new ideas in the various areas of Nanotechnology. This intriguing event has taken the initiative to gather the world class experts both from Academic and Industry in a common platform at Nano 2020 Conferences to share their recent research finding to the world and enlighten other esteemed delegates on latest trends in the field of Nanotechnology. We cordially invite all concerned people from different countries of Europe (UK, London, Spain, Istanbul, Denmark, Netherlands, Germany, France, Italy, Brazil, Turkey, Israel, India, China, Japan) to come join us at our event and make it successful by your participation. Nano 2020 is intended to honor prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Nanotechnology. Young Research’s Awards at Nano 2020 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the Nano 2020. YRF Registration benefits: Young Scientist Award recongination certificate and memento to the winners Nano Congress 2020 provides best Platform for your research through oral presentations. Learn about career improvement with all the latest technologies by networking. Provide an opportunity for research interaction and established senior investigators across the globe in the field of Nanotechnology. It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge. YRF Registration Deadline: Till March 19 – $399 Till March 28 – $499 Till April 10 – $599 Why to attend? Nano 2020 is a unique and exciting opportunity, have been designed in an interdisciplinary manner with a multitude of tracks to showcase the new technology, the new products, the service your industry may bid to a broad international audience. It covers a lot of topics and it will be a nice platform to showcase their recent researches on Nanotechnology Applications. Nano 2020, host presentations from experts across the world in the field of Nanotechnology and anticipates more than 200 participants around the globe with thought provoking Keynote lectures, Oral and Poster presentations. The attending delegates comprise Editorial Board Members of associated global journals. Business networking is an avenue for vendors to have network and B2B meetings with “Top Scientists and Colleagues” and with an effective low-cost marketing method for developing sales and opportunities and contacts. Student Poster Competition is organized at event, to inspire students and recent alumnae to present their unique research which will be later published in the journals. All accepted abstracts will be presented at the poster sessions during the conference. An opportunity to present E-Poster for all the students who cannot attend the conference at 99$ with abstract published in the website with DOI number Live Streaming is a value-added service offering to Speaker. Target Audience: Nanotechnology Professionals Directors of companies in the field of Nanotechnology Leading scientists Biomedical Engineering Medicine and Pharmaceuticals Professors Fellows or postdoctoral students Researchers, CEOs Business Delegates Doctors Young research scientists Medical Colleges Nanotechnology Associations and Societies Manufacturing Medical Devices Companies Healthcare professionals Founders and Employees of the related companies Clinical investigators Conference Highlights: 300+ Participation (70 Industry: 30 Academia) 5+ Keynote Speakers 50+ Plenary Speakers 20+ Exhibitors 14 Innovative Educational Sessions 5+ Workshops B2B Meetings The joy of attending Nano 2020 brings with it improvement and incremental growth in your approach to do things, in the broader manner to see things and the beauty to live international diversity.

The IEEE 4th International Conference for Convergence in Technology (I2CT 2018) will be held in SDMIT, Mangalore, Karnataka, India , from October 27TH to 28TH , 2018. I2CT is one of the premier and reputed international conference in technology , The theme for 4th I2CT 2018 is convergence in Innovative Technology - researchers and engineers will be brought together from academia and industry, and they will freely expose their ideas and opinions on emerging issues in the field of electrical, electronics and computer engineering as well as information technologies. Prospective authors are invited to submit full paper with four to six pages in double-column IEEE conference format via the conference website . More information about paper format and guidelines for paper submission can be found at the conference website. The conference proceedings will be submitted to the IEEE Xplore® digital library. 4th I2ct 2018 will feature both contributed and invited papers.

Dear Colleague, We come across you to inform that the abstract submission (oral and poster contributions) for Nanotech France 2018 and joint events is now extended until Febraury 2, 2018. Over the past editions, Nanotech France 2018 and joint events strengthened its position as an high-level scientific meeting aiming to present a broad range of current research in Nanoscience and Nanotechnology. Submit your abstract by February 2, 2018 Do not miss the chance to present your latest scientific advances in one of the most important nanoevent in France and Europe (Nanotech France 2018, NanoMetrology 2018 and Nanomaterials for Energy and Environment - NanoMatEn 2018) to be held in parallel at the same venue from 27 to 29 June 2018 in Paris, France. Keynote and invited Speakers More than 40 highly ranked nanotechnologists from all around the world already confirmed their attendance. The latest confirmed keynote speakers include: